Combinations of a GLP1R agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders
The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that compr...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
11.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!